BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...GenMark Diagnostics Inc. (NASDAQ:GNMK) said interim president and CEO Scott Mendel will now serve in those...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...GenMark Diagnostics Inc. (NASDAQ:GNMK) said President and CEO Hany Massarany has stepped down. COO Scott Mendel...
BioCentury | Jan 7, 2020
Company News

Management tracks: Rhythm, Mirati, Aura, IFM, a16z, Cambrex, Alzheon and more

...innate immunity to treat cancer. Vor Biopharma Inc. hired Amy Mendel as chief legal officer. Mendel...
BioCentury | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

...Genentech Inc. The TB Alliance hired Eugene Sun as SVP for R&D. He succeeds Carl Mendel...
BioCentury | Feb 2, 2018
Product Development

AA Viral meme

Gene therapy pioneer James Wilson’s revelation of two new types of toxicity in animals receiving high systemic doses of adeno-associated viral vectors is unlikely to herald a major disruption of the AAV space, though it...
BioCentury | May 18, 2017
Targets & Mechanisms

Degrading NASH

...for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease." Cell Metabolism (2017) Mendel...
BioCentury | Apr 7, 2017
Company News

Mendel, Cancer Genetics deal

...Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Mendel Health, San Francisco, Calif. Business: Diagnostic Shannon Lehnbeuter Cancer Genetics Inc. Mendal.ai Mendel...
BioCentury | Sep 26, 2016
Regulation

Not so fast

FDA documents concerning the review of Exondys 51 eteplirsen to treat DMD show that the chorus keening that the approval opens the floodgates for companies to combine shoddy, underpowered studies with patient activism to gain...
BioCentury | Sep 26, 2016
Regulation

How much is enough?

FDA Commissioner Robert Califf boiled the myriad conflicts over whether to grant accelerated approval to Sarepta Therapeutics Inc .'s Exondys 51 eteplirsen down to one fundamental scientific dispute. It all comes down to a disagreement...
BioCentury | Feb 20, 2016
Company News

Management tracks

...Atreca Inc. (Redwood City, Calif.) named Susan Berland EVP and CFO. She was CFO at Mendel Biotechnology Inc....
Items per page:
1 - 10 of 63
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...GenMark Diagnostics Inc. (NASDAQ:GNMK) said interim president and CEO Scott Mendel will now serve in those...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...GenMark Diagnostics Inc. (NASDAQ:GNMK) said President and CEO Hany Massarany has stepped down. COO Scott Mendel...
BioCentury | Jan 7, 2020
Company News

Management tracks: Rhythm, Mirati, Aura, IFM, a16z, Cambrex, Alzheon and more

...innate immunity to treat cancer. Vor Biopharma Inc. hired Amy Mendel as chief legal officer. Mendel...
BioCentury | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

...Genentech Inc. The TB Alliance hired Eugene Sun as SVP for R&D. He succeeds Carl Mendel...
BioCentury | Feb 2, 2018
Product Development

AA Viral meme

Gene therapy pioneer James Wilson’s revelation of two new types of toxicity in animals receiving high systemic doses of adeno-associated viral vectors is unlikely to herald a major disruption of the AAV space, though it...
BioCentury | May 18, 2017
Targets & Mechanisms

Degrading NASH

...for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease." Cell Metabolism (2017) Mendel...
BioCentury | Apr 7, 2017
Company News

Mendel, Cancer Genetics deal

...Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Mendel Health, San Francisco, Calif. Business: Diagnostic Shannon Lehnbeuter Cancer Genetics Inc. Mendal.ai Mendel...
BioCentury | Sep 26, 2016
Regulation

Not so fast

FDA documents concerning the review of Exondys 51 eteplirsen to treat DMD show that the chorus keening that the approval opens the floodgates for companies to combine shoddy, underpowered studies with patient activism to gain...
BioCentury | Sep 26, 2016
Regulation

How much is enough?

FDA Commissioner Robert Califf boiled the myriad conflicts over whether to grant accelerated approval to Sarepta Therapeutics Inc .'s Exondys 51 eteplirsen down to one fundamental scientific dispute. It all comes down to a disagreement...
BioCentury | Feb 20, 2016
Company News

Management tracks

...Atreca Inc. (Redwood City, Calif.) named Susan Berland EVP and CFO. She was CFO at Mendel Biotechnology Inc....
Items per page:
1 - 10 of 63